Aljohara S Almeneessier1, Samar Z Nashwan2,3, Mostafa Q Al-Shamiri4, Seithikurippu R Pandi-Perumal5, Ahmed S BaHammam2,3. 1. Department of Family Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. 2. The University Sleep Disorders Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. 3. The Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia, Riyadh, Saudi Arabia. 4. King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia. 5. Somnogen Canada Inc., College Street, Toronto, ON M6H 1C5, Canada.
Abstract
BACKGROUND: One important cardiovascular morbidity that is associated with obesity hypoventilation syndrome (OHS) is the development of pulmonary hypertension (PH). However, few studies have assessed PH in OHS patients. Therefore, we prospectively assessed the prevalence of PH in a large sample of OHS patients. METHODS: In this prospective observational study, all consecutive OHS patients referred to the sleep disorders clinic during the study period were included. All patients underwent overnight polysomnography (PSG), spirometry, arterial blood samples and thyroid tests. Transthoracic echocardiography was performed for patients who agreed to participate in the study. PH was defined as systolic pulmonary artery pressure (SPAP) >40 mmHg. RESULTS: Echocardiographic data were available for 77 patients with a mean age of 60.5±11.7 years, a BMI of 43.2±10.4 kg/m2, and an Epworth Sleepiness Scale (ESS) score of 11.4±5.5. SPAP was >40 mmHg in 53 patients (68.8%), with a mean SPAP of 64.1±17.1 mmHg. There were no differences between the OHS patients with PH and those with normal PAP in terms of age, BMI, presenting symptoms, comorbidities, arterial blood gasses (ABG), and spirometric and PSG parameters. Approximately 71.4% of women and 61.9% of men with OHS also had PH. SPAP was >40-55 mmHg in 19 (24.7%) patients (18 women), >55-70 mmHg in 15 (19.5%) patients (6 women) and >70 mmHg in 19 (24.7%) patients (16 women). Severe PH (SPAP >70 mmHg) was diagnosed in 28.6% of the women and 14.3% of the men. CONCLUSIONS: PH is very common among patients with OHS who have been referred to sleep disorders clinics. PH should be considered in the regular clinical assessment of all patients with OHS.
BACKGROUND: One important cardiovascular morbidity that is associated with obesity hypoventilation syndrome (OHS) is the development of pulmonary hypertension (PH). However, few studies have assessed PH in OHSpatients. Therefore, we prospectively assessed the prevalence of PH in a large sample of OHSpatients. METHODS: In this prospective observational study, all consecutive OHSpatients referred to the sleep disorders clinic during the study period were included. All patients underwent overnight polysomnography (PSG), spirometry, arterial blood samples and thyroid tests. Transthoracic echocardiography was performed for patients who agreed to participate in the study. PH was defined as systolic pulmonary artery pressure (SPAP) >40 mmHg. RESULTS: Echocardiographic data were available for 77 patients with a mean age of 60.5±11.7 years, a BMI of 43.2±10.4 kg/m2, and an Epworth Sleepiness Scale (ESS) score of 11.4±5.5. SPAP was >40 mmHg in 53 patients (68.8%), with a mean SPAP of 64.1±17.1 mmHg. There were no differences between the OHSpatients with PH and those with normal PAP in terms of age, BMI, presenting symptoms, comorbidities, arterial blood gasses (ABG), and spirometric and PSG parameters. Approximately 71.4% of women and 61.9% of men with OHS also had PH. SPAP was >40-55 mmHg in 19 (24.7%) patients (18 women), >55-70 mmHg in 15 (19.5%) patients (6 women) and >70 mmHg in 19 (24.7%) patients (16 women). Severe PH (SPAP >70 mmHg) was diagnosed in 28.6% of the women and 14.3% of the men. CONCLUSIONS: PH is very common among patients with OHS who have been referred to sleep disorders clinics. PH should be considered in the regular clinical assessment of all patients with OHS.
Authors: Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller Journal: J Am Soc Echocardiogr Date: 2010-07 Impact factor: 5.251
Authors: Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun Journal: Am J Respir Crit Care Med Date: 2009-01-22 Impact factor: 21.405
Authors: Christoph A Kauppert; Iris Dvorak; Florian Kollert; Frank Heinemann; Rudolf A Jörres; Michael Pfeifer; Stephan Budweiser Journal: Respir Med Date: 2013-09-28 Impact factor: 3.415
Authors: Aljohara S Almeneessier; Samar Z Nashwan; Mostafa Q Al-Shamiri; Seithikurippu R Pandi-Perumal; Ahmed S BaHammam Journal: J Thorac Dis Date: 2017-07 Impact factor: 2.895
Authors: Juan F Masa; Iván D Benítez; Shahrokh Javaheri; Maria Victoria Mogollon; Maria Á Sánchez-Quiroga; Francisco J Gomez de Terreros; Jaime Corral; Rocio Gallego; Auxiliadora Romero; Candela Caballero-Eraso; Estrella Ordax-Carbajo; María F Troncoso; Mónica González; Soledad López-Martín; José M Marin; Sergi Martí; Trinidad Díaz-Cambriles; Eusebi Chiner; Carlos Egea; Javier Barca; Ferrán Barbé; Babak Mokhlesi Journal: J Clin Sleep Med Date: 2022-04-01 Impact factor: 4.062
Authors: Melissa A Maloney; Sally L Davidson Ward; Jennifer A Su; Ramon A Durazo-Arvizu; Jacqueline M Breunig; Daniel U Okpara; Emily S Gillett Journal: J Clin Sleep Med Date: 2022-06-01 Impact factor: 4.324
Authors: Hadil A Al Otair; Fayez Elshaer; Alaa Elgishy; Samar Z Nashwan; Aljohara S Almeneessier; Awad H Olaish; Ahmed S BaHammam Journal: J Thorac Dis Date: 2018-10 Impact factor: 2.895
Authors: Karlijn Pellikaan; Anna G W Rosenberg; Anja A Kattentidt-Mouravieva; Rogier Kersseboom; Anja G Bos-Roubos; José M C Veen-Roelofs; Nina van Wieringen; Franciska M E Hoekstra; Sjoerd A A van den Berg; Aart Jan van der Lely; Laura C G de Graaff Journal: J Clin Endocrinol Metab Date: 2020-12-01 Impact factor: 5.958